Affini-T Therapeutics
-
Health/Life Sciences
Juno co-founder launches bold new startup with Fred Hutch colleagues to deal with most cancers
From left: Affini-T scientific co-founders and Fred Hutch investigators Philip Greenberg, Aude Chapuis, and Thomas Schmitt. (Fred Hutch Photos) A…
Read More » -
Health/Life Sciences
Juno’s lasting legacy: How the cell remedy juggernaut influenced biotech in Seattle and past
Juno’s scientific co-founders, from left: Michel Sadelain, Michael Jensen, Isabelle Rivière, Philip Greenberg, Stanley Riddell, and Renier Brentjens. (Juno Therapeutics…
Read More » -
Health/Life Sciences
Biotech vet Phil Greenberg on his new cancer-fighting startup and immunotherapy’s subsequent section
Fred Hutch investigator and Affini-T co-founder Philip Greenberg. (Fred Hutch Photo) Philip Greenberg has been trying to stop cancer for…
Read More » -
Health/Life Sciences
Life sciences information roundup: COVID-19 vaccines developed in Seattle get inexperienced mild, and extra
Structure of the UW COVID-19 vaccine (right). (UW Photo) Two COVID-19 vaccines developed in Seattle got the nod from regulatory…
Read More »